| 1067 |
ATLAS, Lancet 2026
|
2026-07-30 |
135 |
| 1066 |
TRACE-5 BAO, Lancet 2026
|
2026-07-30 |
118 |
| 1065 |
ORIENTAL MEVO Trial, NEJM 2026
|
2026-07-30 |
136 |
| 1064 |
CHAMPION-AF와 CLOSURE-A:우리는 누구에게 LAAC를 해야 하는가?
|
2026-06-30 |
224 |
| 1063 |
Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation
|
2026-06-30 |
202 |
| 1062 |
Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation
|
2026-06-30 |
212 |
| 1061 |
Increased Risk of Ischemic Events in Patients With Stroke Treated With Clopidogrel and a P-CAB or PPI
|
2026-05-28 |
793 |
| 1060 |
Glenzocimab Efficacy and Safety Added to Intravenous Thrombolysis With or Without Mechanical Thrombectomy in Patients With Acute Ischemic Stroke—ACTISAVE
|
2026-05-28 |
337 |
| 1059 |
Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation The STABLED Randomized Clinical Trial
|
2026-05-28 |
300 |
| 1058 |
Asundexian for Secondary Stroke Prevention (OCEANIC-STROKE trial)
|
2026-04-29 |
559 |
| 1057 |
Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage (TRIDENT trial)
|
2026-04-29 |
401 |
| 1056 |
Rescue Versus First-Line Intracranial Stenting During Thrombectomy for Acute Ischemic Stroke: A Propensity-Weighted Analysis of the RESISTANT Registry
|
2026-04-29 |
453 |
| 1055 |
Vasospasm During Endovascular Treatment of Ischemic Stroke; Associated Factors, Impact on Outcomes, and the Effect of Intraarterial Nimodipine
|
2026-04-01 |
797 |
| 1054 |
Preceding Infections and Coagulation Biomarkers in Early-Onset Cryptogenic Ischemic Stroke
|
2026-04-01 |
707 |
| 1053 |
Time-Dependent Impact of Mismatch Profiles on Outcomes Following Endovascular Thrombectomy for Large Ischemic Stroke
|
2026-04-01 |
766 |
HOME
LOGIN
